Management of methicillin-resistant Staphylococcus aureus infections.
about
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infectionsAntimicrobial peptide Epinecidin-1 promotes complete skin regeneration of methicillin-resistant Staphylococcus aureus-infected burn wounds in a swine model.A high-throughput screen for antibiotic drug discoveryEfficacy of topically delivered moxifloxacin against wound infection by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.Ciprofloxacin-Loaded Keratin Hydrogels Prevent Pseudomonas aeruginosa Infection and Support Healing in a Porcine Full-Thickness Excisional Wound.The safety and efficacy of high versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysisAn update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the present and the future.Antibacterial activity of three newly-synthesized chalcones & synergism with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.Infective endocarditis in patients on haemodialysis - possible strategies for prevention.Novel antibiotics for the treatment of Staphylococcus aureus.An Unusual Occurrence of Methicillin Resistant Staphylococcal Endocarditis with Vancomycin Creep Phenomenon - A Therapeutic Challenge.Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment.Assessment of linezolid prescriptions in three French hospitals.Newly-synthesized chalcones-inhibition of adherence and biofilm formation of methicillin-resistant Staphylococcus aureusAntimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.Economic evaluation of treatment for MRSA complicated skin and soft tissue infections in Glasgow hospitals.Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients.Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries.Negative impact of linezolid on human neutrophil functions in vitro.Genotypic characterization of isolated from a burn centre by using and SCC typing methods
P2860
Q26752922-96792148-2210-483C-ADDA-9E35DA36D6ADQ33591448-99BE32AD-B69E-4783-9E22-EA85622ABD51Q33857043-0DEC1C94-27F1-4FF4-B855-A9B6ABECDF80Q34932409-E6134171-60E8-42CD-B2C2-F57601D07C1EQ35191417-2CE6E07E-CB56-4411-AFA5-CB26ADAACB7DQ35861496-547B2870-38F4-431D-B3EE-A89F4675D957Q36148828-6DA96591-EA81-4B2E-B881-F9F915F70907Q38314400-3D9D8A33-6A78-41FF-B40F-655365B39FD0Q39128926-D53AA9BD-B3FE-4CF9-A790-C87F68E03C30Q39662145-7C5C764E-EF25-43CA-9236-BD9E0A5C5B97Q39933945-782895B7-DB2A-475F-B19E-8999F9844202Q40068591-FAEB45EC-CB17-408A-ACB9-7D800920AA4DQ40083539-96B71D5F-38E7-4F78-B178-C6E5040B0A51Q40356411-5DE2FA52-6447-4E78-A979-476A3890B6AFQ40761009-B0025F68-3A28-4491-B6ED-58750B974678Q41443468-7BED896F-E7C4-43F3-B5E2-A2CCCD8400CEQ42249120-7A1850E1-2446-483C-AC60-D024C6FDB135Q47811432-B316BCE4-3686-47D1-A674-0311BC69AE03Q53654914-7D3A8631-28AF-4E41-A87C-0ACB5B90592BQ54333201-0C4A0593-2538-4AFE-8279-A8709BA54BDEQ58788179-8B755F54-0ADE-4800-8C1B-0CCA85D78746
P2860
Management of methicillin-resistant Staphylococcus aureus infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of methicillin-resistant Staphylococcus aureus infections.
@en
Management of methicillin-resistant Staphylococcus aureus infections.
@nl
type
label
Management of methicillin-resistant Staphylococcus aureus infections.
@en
Management of methicillin-resistant Staphylococcus aureus infections.
@nl
prefLabel
Management of methicillin-resistant Staphylococcus aureus infections.
@en
Management of methicillin-resistant Staphylococcus aureus infections.
@nl
P2093
P1476
Management of methicillin-resistant Staphylococcus aureus infections.
@en
P2093
P304
P356
10.1111/J.1469-0691.2009.02701.X
P50
P577
2009-02-01T00:00:00Z